Sara Wallace
Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1174899207
Payments from drug & device makers
What this record shows
This record is dominated by education: $124,733 of the $147,897 with a category attached, or 84.3%. Zimmer Biomet accounts for 94.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $99,898, more than ten times the $365 reported in 2019.
Across 132 payments — averaging $1120.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$140K
- Depuy Synthes Products, Inc.$7K
- Stryker$470
- Medical Device Business Services, Inc.$137
- Intellijoint Surgical Inc.$21
- KCI USA, Inc.$14
What the payments were for
- Consulting fees$8,8756%
- Travel & lodging$9,8967%
- Food & beverage$4,3943%
- Education$124,73384%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 114 | $139,940 |
| Depuy Synthes Products, Inc. | 8 | $7,315 |
| Stryker | 7 | $470 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Intellijoint Surgical Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$147,897 in reported general payments places this provider in the 85th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 28 | $505 |
| Gabapentin | 23 | $167 |
| Amoxicillin | 44 | $108 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Chicago
- Denis NamChicago$3.2M
- Craig della ValleChicago$2.4M
- Hany BedairChicago$1.1M
- Linda SuleimanChicago$898K
- Tad GerlingerChicago$642K
- Henry FinnChicago$523K
- Vasili KarasChicago$264K
- Brett LevineChicago$250K
- Joshua JacobsChicago$72K
- William ThomasChicago$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.